Ownership and insider activity for None (AARD): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders. The company's primary experimental drug, ARD-101, is an orally administered, gut-specific small molecule.
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-10 | Sun Nelson | S-Sale | 14,754 | $74K |
| 2026-09-11 | Sun Nelson | S-Sale | 62,000 | $321K |
| 2026-08-14 | Chi Jeffrey | A-Award | 44,964 | $294K |
| 2026-08-14 | Graf Susan E | A-Award | 44,964 | $294K |
| 2026-08-14 | Baynes Roy D. | A-Award | 44,964 | $294K |
| 2026-08-14 | Tong Victor Edward Jr | A-Award | 44,964 | $294K |
| 2026-02-09 | Sun Nelson | A-Award | 70,549 | $951K |
| 2026-02-09 | Jaiman Manasi | A-Award | 70,549 | $951K |
| 2026-02-09 | Lee Tien-Li | A-Award | 203,851 | $2.7M |
| 2025-12-11 | Sun Nelson | P-Purchase | 3,000 | $43K |
Balance Sheet (10y)
| Year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $15.6M | $9.7M | $61.6M | $47.1M |
| Short-term Investments | $546000 | $254000 | $12.0M | $63.0M |
| Receivables | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 |
| Total Current Assets | $16.5M | $10.4M | $74.1M | $111.9M |
| Property, Plant & Equipment | $252000 | $155000 | $735000 | $355000 |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Total Assets | $16.8M | $10.5M | $77.5M | $117.2M |
| Accounts Payable | $259000 | $1.0M | $2.3M | $2.1M |
| Short-term Debt | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $595000 | $1.4M | $4.9M | $10.5M |
| Long-term Debt | 0 | 0 | 0 | 0 |
| Total Liabilities | $44.7M | $45.3M | $132.2M | $10.5M |
| Retained Earnings | -$30.5M | -$37.7M | -$58.3M | -$115.9M |
| Total Equity | -$27.9M | -$34.8M | -$54.6M | $106.6M |
| Total Debt | $262000 | $162000 | $779000 | $441000 |
| Net Debt | -$15.8M | -$9.8M | -$72.9M | -$109.6M |
| Working Capital | $15.9M | $9.0M | $69.2M | $101.3M |
Related companies: ASMB · AVTX · CRBU · ENTA · EPRX · FHTX · NAUT
More sections of AARD: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks